Thyrocare Technologies Resultados de beneficios anteriores
Todavía estamos procesando el último informe de beneficios de esta empresa
Pasado controles de criterios 1/6
Los beneficios de Thyrocare Technologies han disminuido a una tasa media anual de -1.1%, mientras que en la industria Healthcare los beneficios crecieron en un 29.7% anualmente. Los ingresos han ido creciendo a una tasa media de 7.3% al año. La rentabilidad financiera de Thyrocare Technologies es de 13.3%, y sus márgenes netos son de 11.8%.
Información clave
-1.1%
Tasa de crecimiento de los beneficios
-1.0%
Tasa de crecimiento del BPA
Crecimiento de la industria Healthcare | 29.4% |
Tasa de crecimiento de los ingresos | 7.3% |
Rentabilidad financiera | 13.3% |
Margen neto | 11.8% |
Última actualización de beneficios | 31 Dec 2023 |
Actualizaciones de resultados anteriores recientes
Recent updates
Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult
Feb 29Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 04Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly
Dec 08Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 08Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively
Mar 23Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Mar 02Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First
Feb 01Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%
Jan 12The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares
Dec 24Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive
Dec 17Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 30Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Nov 02Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates
Nov 01How Does Thyrocare Technologies Limited (NSE:THYROCARE) Fare As A Dividend Stock?
Oct 28Insider Buying: The Thyrocare Technologies Limited (NSE:THYROCARE) Chairman Just Bought ₹20m Worth Of Shares
Oct 07The Thyrocare Technologies (NSE:THYROCARE) Share Price Has Gained 51% And Shareholders Are Hoping For More
Sep 29Will Thyrocare Technologies (NSE:THYROCARE) Repeat Its Return Growth Of The Past?
Sep 11Trade Alert: The Chairman Of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Has Just Spent ₹9.6m Buying A Few More Shares
Aug 22Thyrocare Technologies Limited's (NSE:THYROCARE) Price In Tune With Earnings
Aug 17Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Jul 30Investor Optimism Abounds Thyrocare Technologies Limited (NSE:THYROCARE) But Growth Is Lacking
Jul 28Should Weakness in Thyrocare Technologies Limited's (NSE:THYROCARE) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jul 04Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Thyrocare Technologies. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
31 Dec 23 | 5,535 | 655 | 121 | 0 |
30 Sep 23 | 5,468 | 648 | 121 | 0 |
30 Jun 23 | 5,338 | 599 | 121 | 0 |
31 Mar 23 | 5,267 | 644 | 121 | 0 |
31 Dec 22 | 5,214 | 731 | 83 | 0 |
30 Sep 22 | 5,108 | 800 | 83 | 0 |
30 Jun 22 | 5,520 | 1,423 | 83 | 0 |
31 Mar 22 | 5,889 | 1,761 | 83 | 0 |
31 Dec 21 | 6,051 | 1,924 | 65 | 0 |
30 Sep 21 | 6,260 | 2,032 | 65 | 0 |
30 Jun 21 | 6,030 | 1,685 | 73 | 0 |
31 Mar 21 | 4,946 | 1,132 | 65 | 0 |
31 Dec 20 | 4,503 | 741 | 69 | 0 |
30 Sep 20 | 4,178 | 692 | 69 | 0 |
30 Jun 20 | 3,797 | 612 | 0 | 0 |
31 Mar 20 | 4,343 | 884 | 69 | 0 |
31 Dec 19 | 4,384 | 1,063 | 244 | 0 |
30 Sep 19 | 4,289 | 990 | 244 | 0 |
30 Jun 19 | 4,165 | 892 | 244 | 0 |
31 Mar 19 | 4,039 | 851 | 244 | 0 |
31 Dec 18 | 3,946 | 939 | 237 | 0 |
30 Sep 18 | 3,822 | 953 | 237 | 0 |
30 Jun 18 | 3,663 | 947 | 237 | 0 |
31 Mar 18 | 3,569 | 933 | 237 | 0 |
31 Dec 17 | 3,493 | 1,117 | 125 | 0 |
30 Sep 17 | 3,359 | 994 | 125 | 0 |
30 Jun 17 | 3,258 | 759 | 0 | 0 |
31 Mar 17 | 3,045 | 428 | 220 | 0 |
31 Dec 16 | 2,843 | 659 | 120 | 0 |
30 Sep 16 | 2,699 | 601 | 120 | 0 |
30 Jun 16 | 2,535 | 564 | 120 | 0 |
31 Mar 16 | 2,411 | 518 | 120 | 0 |
31 Mar 15 | 1,835 | 452 | 69 | 0 |
31 Mar 14 | 1,502 | 462 | 57 | 0 |
Ingresos de calidad: THYROCARE tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio(11.8%) de THYROCARE son inferiores a los del año pasado (14%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de THYROCARE han disminuido en un 1.1% al año en los últimos 5 años.
Acelerando crecimiento: THYROCARE ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: THYROCARE tuvo un crecimiento negativo de los beneficios (-10.5%) durante el año pasado, lo que dificulta la comparación con la media de la industria Healthcare (29.5%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de THYROCARE (13.3%) se considera baja.